S&P 5007,691▲ 0.41%Nasdaq26,431▲ 1.11%Dow Jones51,966▼ 0.07%Nasdaq 10029,529▲ 1.17%VIX18.44▼ 7.75%US Dollar101.97▲ 0.13%Gold spot4,165▲ 0.21%WTI spot101.91▲ 1.04%
Home › CPHL › Research report
← CPHL page
XStocksXray
Market X-Ray report · 19 October 2026

Citi Pharma Ltd (CPHL)

Karachi Stock Exchange · Pakistan · prices in PKR · close of 19 Oct 2026

Key indicators

Last closePKR 62.35
52-week range61.20 – 93.99
Return, 1 month / 3 months−17.3% / −16.9%
Return, 1 year / 3 years−31.8% / +293.1%
TrendBelow its 200-day average
RSI (14)26
Volatility (1 year)37.9%
Worst drawdown (1 year)-33.7%
Average daily value traded73.47M PKR
Dividend yield–

Market X-Ray price-based

47/ 100 · High confidence · ahead of 44% of stocks on this exchange
Trend24
Momentum20
Stability (higher is calmer)77
Liquidity83
Income–

Fair value limited data

Average of 3 modelsPKR 75.11Model uncertainty High
Versus priceUndervalued+21% to fair value

Five-year price chart navy: price · brown: 200-day average · blue band: fair value range

8.6633.4658.2683.06108Fair value $752021-102023-012024-042025-072026-10

Summary

Citi Pharma Ltd (CPHL) trades on the Karachi Stock Exchange in Pakistan. It last closed at PKR 62.35 on 19 October 2026.

Its price-based Market X-Ray is 47 out of 100 (a weak price profile), ranking 274 of 491 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 31.8% and over the last three months it fell 16.9%. Returns are price returns, dividends not included.

Our limited-data fair value is PKR 75.11 (Undervalued, +20.5% to fair value). It averages 3 models built from the earnings and sales this exchange publishes. Their weights were fitted to a professional consensus-style valuation of Pakistani stocks and checked on stocks left out of the fit, but no analyst forecasts are used, so read it as a rough range.

stocksxray.com · page 1
XStocksXray
Citi Pharma Ltd (CPHL)

The five lenses in numbers each metric is ranked against the other stocks on Karachi Stock Exchange

Lens and metricValueScoreReading
Trend24 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-20.0%
From 52-week high-32.9%
Momentum20 · WeakLagging most stocks on this exchange.
3-month return-16.9%
6-month return-22.0%
12-month return, skipping the last month-17.6%
Stability (higher is calmer)77 · StrongCalmer than most: low volatility and shallow drawdowns.
Volatility, 1 year (lower is calmer)37.9%
Worst drawdown, 1 year (smaller is calmer)-33.7%
Liquidity83 · StrongTrades actively.
Average daily value traded73.47M PKR
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends3

Strengths

  • Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
  • Liquidity: Trades actively.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Momentum: Lagging most stocks on this exchange.

Returns

1 week−2.0%
1 month−17.3%
3 months−16.9%
6 months−22.0%
1 year−31.8%
3 years+293.1%
5 years–

Signals

50-day / 200-day average71.39 / 77.90
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)1.82

Technical summary

DailyStrongly bearish3 bullish · 1 neutral · 12 bearish
WeeklyStrongly bearish1 bullish · 1 neutral · 10 bearish
MonthlyBearish2 bullish · 1 neutral · 5 bearish

Recent dividends

Ex-dividend dateAmount per share
17 Oct 2025PKR 3.5000
17 Oct 2024PKR 3.2500
25 Oct 2023PKR 2.5000
18 Oct 2023PKR 2.5000
18 Oct 2021PKR 1.6500

Fair value models PSX income statement only (no balance sheet or cash flow): only earnings, sales and dividend models can be built

P/E multiplePKR 74.16
P/S multiplePKR 76.48
P/E on average earningsPKR 74.71

How to read this report

Every number comes from end-of-day prices and dividends and the earnings and sales this exchange publishes. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Karachi Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 20 Oct 2026